PHARMA


Pages
37
Language
English
Published on
27/09/17

EXECUTIVE SUMMARY

We diagnose chronic illness for the sector as its long-held pricing tooth decays and accountability is forced upon it.

This study discovers and explains why life won’t be same (or as good) again!

Our Lead Analyst on Healthcare & Pharma has published her latest note entitled “Tough times ahead”.

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO